By Vin Gurrieri ( February 11, 2016, 2:07 PM EST) -- An Illinois federal judge on Wednesday largely allowed multidistrict litigation to move forward accusing Endo International PLC of engaging in an alleged scheme to pay Impax Laboratories Inc. more than $112 million to delay a generic version of opioid pain medication Opana ER, trimming only a handful of state law claims. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.